Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

關於 Helius Medical Technologies

成立時間2014
Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.
社群
LinkedIn
Website
標簽
Publicly listed company
Crypto Stocks

熱度值變化趨勢

團隊成員

Dane C. Andreeff
Dane C. Andreeff

President and Chief Executive Officer

Jeffrey S. Mathiesen
Jeffrey S. Mathiesen

Chief Financial Officer

投資方

Pantera Capital
Pantera Capital
Summer Capital
Summer Capital

投融資詳情

Post-IPO(2025-09-14)
金額$158.77億
投資方
Pantera Capital
Pantera Capital
Summer Capital
Summer Capital
估值--